Adenoviral reporter gene transfer to the human trabecular meshwork does not alter aqueous humor outflow. Relevance for potential gene therapy of glaucoma

Gene Therapy

Volumn 6, Issue 4, 1999, Pages 515-524

  Borras T ^a   Rowlette, L L ^a   Erzurum, S C ^b   Epstein, D L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Adenoviral vectors; Aqueous humor outflow facility; Gene therapy; Glaucoma; Trabecular meshwork

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; AQUEOUS HUMOR OUTFLOW; ARTICLE; CONTROLLED STUDY; DNA REPLICATION; GENE THERAPY; GENE TRANSFER; GLAUCOMA; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAOCULAR PRESSURE; ORGAN CULTURE; PRIORITY JOURNAL; REPORTER GENE; TRABECULAR MESHWORK;

ADENOVIRIDAE; ANIMALS; ANTERIOR EYE SEGMENT; AQUEOUS HUMOR; BETA-GALACTOSIDASE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLAUCOMA; HISTOCYTOCHEMISTRY; HUMANS; INTRAOCULAR PRESSURE; MODELS, BIOLOGICAL; ORGAN CULTURE TECHNIQUES; SWINE; TRABECULAR MESHWORK;

ADENOVIRIDAE; SUIDAE;

EID: 0032906557     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300860     Document Type: Article

References (53)

1. Quigley HA. Number of people with glaucoma worldwide (see comments). Br J Ophthalmol 1996; 80: 389-393.
2. Kupfer C, Underwood B, Gillen T. Leading causes of visual impairment worldwide. In: Albert DM, Jakobiec FA (eds). Principles and Practice of Ophthalmology Saunders: Philadelphia, 1994, pp 1249-1255.
3. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989; 107: 186-188.
4. Quigley HA. Open-angle glaucoma (see comments). New Engl J Med 1993; 328: 1097-1106.
5. Rohen JW, van der E Zypen. The phagocytic activity of the trabecular meshwork endothelium. An electron-microscopic study of the vervet (Cercopithecus aethiops). Albrecht Von Graefes Archiv fur Klinische und Experimentelle Ophthalmologie 1968; 175:143-160.
6. Bill A. The drainage of aqueous humor. Invest Ophthalmol 1975; 14: 1-3.
7. Alexander JP, Samples JR, Van Buskirk EM, Acott TS. Expression of matrix metalloproteinases and inhibitor by human trabecular meshwork. Invest Ophthalmol Vis Sci 1991; 32: 172-180.
8. Johnson DH, Richardson TM, Epstein DL. Trabecular meshwork recovery after phagocytic challenge. Curr Eye Res 1989; 8: 1121-1130.
9. Quigley HA, Flower RW, Addicks EM, McLeod DS. The mechanism of optic nerve damage in experimental acute intraocular pressure elevation. Invest Ophthalmol Vis Sci 1980; 19: 505-517.
10. Graham FL, Prevec L. Manipulation of adenoviral vectors. In: Murray EJ (ed). Methods in Molecular Biology. Humana Press: Clifton, NJ, 1991, pp 109-128.
11. Berkner KL. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 1988; 6: 616-629.
12. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
13. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
14. Borrás T, Tamm ER, Zigler JS Jr. Ocular adenovirus gene transfer varies in efficiency and inflammatory response. Invest Ophthalmol Vis Sci 1996; 37: 1282-1293.
15. Bennett J et al. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest Ophthalmol Vis Sci 1994; 35: 2535-2542.
16. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest Ophthalmol Vis Sci 1995; 36: 2211-2215.
17. Abraham NG et al. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues. Invest Ophthalmol Vis Sci 1995; 36: 2202-2210.
18. Fehervari Z et al. Gene transfer to ex vivo stored corneas. Cornea 1997; 16: 459-464.
19. Larkin DF et al. Adenovirus-mediated gene delivery to the corneal endothelium. Transplantation. 1996; 61: 363-370.
20. Borrás T, Matsumoto Y, Epstein DL et al. Gene transfer to the human trabecular meshwork by anterior segment perfusion. Invest Ophthalmol Vis Sci 1998; 39: 1503-1507.
21. Erickson-Lamy K, Schroeder AM, Bassett-Chu S, Epstein DL. Absence of time-dependent facility increase ('washout') in the perfused enucleated human eye. Invest Ophthalmol Vis Sci 1990; 31: 2384-2388.
22. Epstein DL et al Experimental obstruction to aqueous outflow by pigment particles in living monkeys. Invest Ophthalmol Vis Sci 1986; 27: 387-395.
23. Trapnell BC. Adenoviral vectors for gene transfer. Adv Drug Del Rev 1993; 12: 185-199.
24. Erzurum SC et al. Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Research 1993; 21: 1607-1612.
25. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.
26. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR. Integrin alpha v beta 5 selectively promotes adenovirus-mediated cell membrane permeabilization. J Cell Biol 1994; 127: 257-264.
27. Mathias P, Wickham T, Moore M, Nemerow G. Multiple adenovirus serotypes use alpha v integrins for infection. J Virol 1994; 68: 6811-6814.
28. Nevins JR et al. Regulation of the primary expression of the early adenovirus transcription units. J Virol 1979; 32: 727-733.
29. Ellingsen BA, Grant WM. Trabeculotomy and sinusotomy in enucleated human eyes. Invest Ophthalmol 1972; 11: 21-28.
30. Grant WM. Experimental aqueous perfusion in enucleated human eyes. Arch Ophthalmol 1963; 69: 783-801.
31. Grant WM. Further studies on facility of flow through the trabecular meshwork. Arch Ophthalmol 1958; 60: 523-533.
32. Rosenquist R et al. Outflow resistance of enucleated human eyes at two different perfusion pressures and different extents of trabeculotomy. Curr Eye Res 1989; 8: 1233-1240.
33. Mäepea O, Bill A. Pressures in the juxtacanalicular tissue and Schlemm's canal in monkeys. Exp Eye Res 1992; 54: 879-883.
34. Grant WM, Schuman JS. The angle of the aanterior chamber. In: Epstein DL, Allingham RR, Schuman JS (eds). Chandler and Grant's Glaucoma. Williams & Wilkins: Baltimore, MD, 1996, pp 51-83.
35. Oral HB et al. Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. Gene Therapy 1997; 4: 639-647.
36. Huggert A. Pore size in the filtration angle of the eye. Acta Ophthalmol 1955; 33: 271-284.
37. Huggert A. An experiment in determining the pore size distribution curve to the filtration angle of the eye. Acta Ophthalmol 1957; 35: 12-19.
38. Barany E. Pore size and passage of particulate matter through the trabecular meshwork. Doc Ophthalmol 1959; 13: 41-55.
39. Johnson M et al. The filtration characteristics of the aqueous outflow system. Exp Eye Res 1990; 50: 407-418.
40. Stone EM et al. Identification of a gene that causes primary open angle glaucoma (see comments). Science 1997; 275: 668-670.
41. Masuda I, Matsuo T, Yasuda T, Matsuo N. Gene transfer with liposomes to the intraocular tissues by different routes of administration. Invest Ophthalmol Vis Sci 1996; 37: 1914-1920.
42. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
43. Channon KM et al. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res 1996; 32: 962-972.
44. Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 1979; 17: 683-689.
45. Friedman JM, Babiss LE, Clayton DF, Darnell JE, Jr. Cellular promoters incorporated into the adenovirus genome: cell specificity of albumin and immunoglobulin expression. Molec Cell Bid 1986; 6: 3791-3797.
46. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52: 456-467.
47. Johnson DH, Tschumper RC. Human trabecular meshwork organ culture. A new method. Invest Ophthalmol Vis Sci 1987; 28: 945-953.
48. Johnson DH, Tschumper RC. The effect of organ culture on human trabecular meshwork. Exp Eye Res 1989; 49: 113-127.
49. Johnson DH. Human trabecular meshwork cell survival is dependent on perfusion rate. Invest Ophthalmol Vis Sci 1996; 37: 1204-1208.
50. Epstein DL, Hashimoto JM, Anderson PJ, Grant WM. Effect of iodoacetamide perfusion on outflow facility and metabolism of the trabecular meshwork. Invest Ophthalmol Vis Sci 1981; 20: 625-631.
51. Epstein DL et al. Influence of ethacrynic acid on outflow facility in the monkey and calf eye. Invest Ophthalmol Vis Sci 1987; 28: 2067-2075.
52. Epstein DL, Hooshmand LB, Epstein MP. Thiol adducts of ethacrynic acid increase outflow facility in enucleated calf eyes. Curr Eye Res 1992; 11: 253-258.
53. Epstein DL, Patterson MM, Rivers SC, Anderson PJ. N-ethylmaleimide increases the facility of aqueous outflow of excised monkey and calf eyes. Invest Ophthalmol Vis Sci 1982; 22: 752-756.